RxDoctor Payments Data

Lindsey Meder, NP

Family · Beachwood, OHNPI 1891210373

Payments from drug & device makers

$1,603in general payments, 2019–2025

Across 52 payments — averaging $30.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$473
  • Boston Scientific$210
  • Impulse Dynamics (USA) Inc.$152
  • AstraZeneca$114
  • Novo Nordisk$103
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$80
  • plus $471 from 13 others

What the payments were for

  • Food & beverage$1,603100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,603 in reported general payments places this provider in the 75th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$31,818
Medicare patients
240
Services billed
402

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban317$397,573
XareltoRivaroxaban87$91,642
Dofetilide122$40,111
EntrestoSacubitril/Valsartan16$14,652
Flecainide Acetate123$5,909
Metoprolol Succinate210$2,843
Amiodarone Hcl101$2,319
Mexiletine Hcl15$1,093
ClopidogrelClopidogrel Bisulfate81$706
Metoprolol Tartrate98$559
SotalolSotalol Hcl13$341
Carvedilol23$169
Spironolactone23$136
Furosemide23$127
Lisinopril25$64

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$68$91,64287 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,812 family providers in Ohio.

Other family in Beachwood

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →